share_log

藥明生物：翌日披露報表

WUXI BIO: Next Day Disclosure Return

香港交易所 ·  Apr 5 19:21
Summary by Futu AI
药明生物（WuXi Biologics (Cayman) Inc.）於2024年4月5日提交了翌日披露報表，披露了自2023年12月7日至2024年4月5日期間的股份購回活動。該公司在此期間通過香港聯合交易所購回了總計88,662,000股普通股，佔當時已發行股份的2.08694%。最近一次購回發生在2024年4月5日，當日購回1,485,000股，每股價格介於13.32港元至13.5港元之間，總支付金額為19,892,520港元。药明生物確認，所有購回行為均符合香港聯交所主板上市規則的相關規定。
药明生物（WuXi Biologics (Cayman) Inc.）於2024年4月5日提交了翌日披露報表，披露了自2023年12月7日至2024年4月5日期間的股份購回活動。該公司在此期間通過香港聯合交易所購回了總計88,662,000股普通股，佔當時已發行股份的2.08694%。最近一次購回發生在2024年4月5日，當日購回1,485,000股，每股價格介於13.32港元至13.5港元之間，總支付金額為19,892,520港元。药明生物確認，所有購回行為均符合香港聯交所主板上市規則的相關規定。
WuXi Biologics (Cayman) Inc., filed a Next Day Disclosure Report on April 5, 2024, disclosing share repurchase activities from December 7, 2023 to April 5, 2024. The company repurchased a total of 88,662,000 shares of ordinary shares through the Hong Kong Stock Exchange during this period, representing 2.08694% of the shares issued at the time. The most recent repurchase took place on 5 April 2024 and repurchased 1,485,000 shares at a price of between HK$13.32 and HK$13.5 per share for a total payment of HK$19,892,520. Pharmaceutical Biologics confirms that all repurchases comply with the relevant provisions of the HKEX Main Board Listing Rules.
WuXi Biologics (Cayman) Inc., filed a Next Day Disclosure Report on April 5, 2024, disclosing share repurchase activities from December 7, 2023 to April 5, 2024. The company repurchased a total of 88,662,000 shares of ordinary shares through the Hong Kong Stock Exchange during this period, representing 2.08694% of the shares issued at the time. The most recent repurchase took place on 5 April 2024 and repurchased 1,485,000 shares at a price of between HK$13.32 and HK$13.5 per share for a total payment of HK$19,892,520. Pharmaceutical Biologics confirms that all repurchases comply with the relevant provisions of the HKEX Main Board Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.